(MENAFN- PR Newswire)
"The Board of Directors is delighted to welcome Steve Granzyk as a board member and the new CEO of Seven Bridges Specialty," said Jeff Fisher, co-founder and Board Chairman of Seven Bridges Specialty. "Steve's exceptional track record in transforming companies into market leaders and his commitment to delivering innovative solutions for our pharma partners make him the ideal leader to position Seven Bridges for high-impact growth."
"I am honored to lead Seven Bridges Specialty as we drive growth in some of the most critical niches within the specialty market," said Granzyk. "It is a privilege to collaborate once again with the exceptional leadership of 653 Investment Partners, including Jeff Fisher, Don Howard, and Sean Creehan, whose vision and success have been unparalleled."
"With a focused approach to advancing patient care in rare disease markets and increased investments in our team and technology, Seven Bridges is poised to redefine the patient experience. We aim to break away from outdated technologies and traditional models, delivering modern, flexible, and innovative solutions that meet the unique needs of patients, providers, and pharma stakeholders."
"I look forward to partnering with our pharma clients to implement cutting-edge programs that ensure optimal outcomes for patients and elevate the overall healthcare experience," added Granzyk.
About Seven Bridges Specialty, LLC
At Seven Bridges Specialty, we are transforming specialty care by building connections across the critical pathways of healthcare. With a focus on our seven core strengths-rare disease expertise, cell and gene therapy support, free goods programs, select specialty products, personalized specialty services, advanced technology, and pharmaceutical partnerships-we simplify the complexities of care with precision and compassion.
By delivering tailored solutions, leveraging cutting-edge technology, and collaborating with industry leaders, we ensure patients can access life-changing therapies with ease. Every step we take is driven by a commitment to bridging gaps in care and improving lives with agility, innovation, and impact. For more information on Seven Bridges Specialty, visit .
About 653 Investment Partners
653 Investment Partners is a private investment firm led by entrepreneurs. Focused on healthcare and technology, our unique blend of experience is rich in demonstrated success through clear vision, hard work, strong relationships, and steadfast commitment to execution. We align with passionate entrepreneurs and companies, offering clear value to their clients. We support them with additional investment, ingenuity, and integrity to help scale their business, the delivery of their value story, and the realization of their full potential. For more information on 653 Investment Partners, visit .
Company Contact:
[email protected] .
Media Contact
Cassandra Dump
[email protected]
(619) 971-1887
SOURCE Seven Bridges Specialty
MENAFN23012025003732001241ID1109122563
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.